Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Teva Pharmaceutical Industries
Pharma
Teva snares up to $150M in Abingworth funding for inhaler program
Shortly after Gilead teamed up with Abingworth to fuel further research on Trodelvy, Teva is following a similar pathway for an asthma rescue inhaler.
Eric Sagonowsky
Apr 1, 2024 10:51am
Biogen notches another Tecfidera patent win in Europe
Dec 19, 2023 9:30am
AbbVie, Boehringer and more face FTC ire for 'improper' patents
Nov 7, 2023 2:22pm
Teva seeks appeal of recent ruling in federal kickbacks case
Jul 27, 2023 11:30am
Exelixis, Teva settle patent litigation with 2031 license
Jul 24, 2023 10:05am
Gilead, Teva and J&J's HIV antitrust case inches closer to trial
Feb 22, 2023 3:50pm